Aprea Therapeutics Inc (APRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2018 | 12-2017 | |
| Cash Flows From Operating Activities | ||
| Net Income | -10,849 | -15,190 |
| Depreciation Amortization | 7 | 8 |
| Accounts payable and accrued liabilities | -216 | N/A |
| Other Working Capital | -65 | 1,447 |
| Other Operating Activity | -276 | -267 |
| Operating Cash Flow | $-11,399 | $-14,002 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -5 | 0 |
| Investing Cash Flow | $-5 | $0 |
| Cash Flows From Financing Activities | ||
| Common Stock Issued | 1 | N/A |
| Other Financing Activity | 0 | 23,344 |
| Financing Cash Flow | $1 | $23,344 |
| Exchange Rate Effect | -645 | 1,395 |
| Beginning Cash Position | 24,402 | 13,665 |
| End Cash Position | 12,354 | 24,401 |
| Net Cash Flow | $-12,047 | $10,736 |
| Free Cash Flow | ||
| Operating Cash Flow | -11,399 | -14,002 |
| Capital Expenditure | -5 | N/A |
| Free Cash Flow | -11,404 | -14,002 |